Amphastar Pharmaceuticals Profit Margin 2012-2018 | AMPH

Current and historical gross margin, operating margin and net profit margin for Amphastar Pharmaceuticals (AMPH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Amphastar Pharmaceuticals net profit margin as of December 31, 2018 is -1.96%.
Amphastar Pharmaceuticals Annual Profit Margins
Amphastar Pharmaceuticals Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.979B $0.295B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.453B 8.36
Teva Pharmaceutical Industries (TEVA) Israel $15.253B 5.26
Mylan (MYL) United Kingdom $13.642B 5.77
Bausch Health Cos (BHC) Canada $8.049B 5.72
Dr Reddy's Laboratories (RDY) India $6.783B 27.05
Supernus Pharmaceuticals (SUPN) United States $1.934B 17.94
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.520B 2.47
Homology Medicines (FIXX) United States $0.829B 0.00
Voyager Therapeutics (VYGR) United States $0.774B 0.00
CymaBay Therapeutics (CBAY) United States $0.756B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.417B 0.00
Assembly Biosciences (ASMB) United States $0.399B 0.00
Akorn (AKRX) United States $0.365B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.211B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.173B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Acasti Pharma (ACST) Canada $0.070B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.064B 0.00
Agile Therapeutics (AGRX) United States $0.064B 0.00
Teligent (TLGT) United States $0.054B 0.00
China Pharma Holdings (CPHI) China $0.016B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.012B 0.00